Other ways to search: Events Calendar | UTHSC

Newly Developed mRNA Vaccine Protects Against Lyme Disease


Consequently, researchers are seeking approaches that prevent new infections. In a recently published Molecular Therapy paper, scientists produced an mRNA-based vaccine against Lyme disease. “I think that for Lyme disease vaccines, the more options, the better,” said Maria Gomes-Solecki, a microbiologist and immunologist from the University of Tennessee Health Science Center, who was not involved in the study. Her team recently developed an intranasal, viral vector-delivered vaccine based on OspA and summarized their results in a preprint posted on Research Square.

Top Publishers